Topical mitomycin C application before myringotomy and ventilation tube insertion: does it affect the final outcome?

Area of Science:

• Otolaryngology
• Pediatric Otology
• Surgical Innovation

Background:

• Topical mitomycin C has shown promise in animal models for prolonging myringotomy opening patency.
• Its efficacy in conjunction with ventilation tube insertion in humans remains unestablished.
• Otitis media with effusion is a common pediatric condition requiring intervention.

Purpose of the Study:

• To evaluate the effectiveness of topical mitomycin C in improving outcomes following myringotomy and ventilation tube insertion.
• To assess the impact of mitomycin C on ventilation tube duration and postoperative complications.
• To determine if mitomycin C offers a clinical benefit in pediatric patients with resistant otitis media with effusion.

Main Methods:

• A randomized, controlled, bilateral study design was employed in children aged 2-12 years.
• Mitomycin C was applied to one ear, while normal saline served as the control for the contralateral ear.
• Key outcome measures included ventilation tube extrusion time and incidence of surgical complications.

Main Results:

• No statistically significant differences were observed in the duration of tube placement between mitomycin C-treated and control ears.
• The incidence of early and late postoperative complications did not differ significantly between the two groups.
• Patient follow-up included 40 children (80 ears) after 15 were lost.

Conclusions:

• Topical mitomycin C application prior to myringotomy and ventilation tube insertion does not appear to be clinically beneficial.
• The use of mitomycin C in this context is not recommended based on the study's findings.
• Further research may be needed to explore alternative applications or patient populations.